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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYHere we show that bivalent domains and chromosome architecture for bivalent genes are dynamically regulated during the cell cycle in
human pluripotent cells. Central to this is the transient increase in H3K4-trimethylation at developmental genes during G1, thereby
creating a ‘‘window of opportunity’’ for cell-fate specification. This mechanism is controlled by CDK2-dependent phosphorylation of
theMLL2 (KMT2B) histonemethyl-transferase, which facilitates its recruitment to developmental genes in G1.MLL2 binding is required
for changes in chromosome architecture around developmental genes and establishes promoter-enhancer looping interactions in a cell-
cycle-dependentmanner. These cell-cycle-regulated loops are shown to be essential for activation of bivalent genes and pluripotency exit.
These findings demonstrate that bivalent domains are established to control the cell-cycle-dependent activation of developmental genes
so that differentiation initiates from the G1 phase.INTRODUCTION
Transcription start sites (TSSs) of developmentally regu-
lated genes are frequently marked by overlapping domains
of active (H3K4me3) and repressive (H3K27me3) histone
marks. These ‘‘bivalent’’ domains are generally believed to
be stable in self-renewing pluripotent stem cells (PSCs)
and serve to establish a ‘‘poised’’ transcriptional state (Bern-
stein et al., 2006; Mikkelsen et al., 2007). During lineage
specification, the bivalent state is resolved, allowing
developmental genes to be activated or more stably
repressed, depending on the lineage being specified. The
molecular mechanisms underpinning these epigenetic
changes are poorly understood but are ultimately regulated
through the concerted action of histone methyl-transfer-
ases (HMTs) and histone de-methylases (Voigt et al.,
2013). In PSCs, H3K4me3 is established through the activ-
ity of trxG complexes containingMLL or SETenzymes (Ble-
dau et al., 2014; Denissov et al., 2014; Hu et al., 2013),
while the PRC2 complex establishes domains of H3K27 tri-
methylation (Boyer et al., 2006; Lee et al., 2006). JARID1 is
thought to be important for the erasure of H3K4me3
(Christensen et al., 2007), while de-methylation of
H3K27me3 is controlled by the activity of JMJD3 and
UTX complexes (Agger et al., 2007). Although significant
effort has been placed on understanding the biochemical
role of these HMT complexes, only limited information is
available on how this network of epigenetic modifiers is
controlled in the pluripotent state and how they poise cells
during the initial stages of differentiation.Stem CellA growing amount of evidence indicates that PSCs
initiate their differentiation program from the G1 phase
of the cell cycle where they are most susceptible to specifi-
cation cues (Chetty et al., 2013; Jonk et al., 1992; Mum-
mery et al., 1987; Pauklin and Vallier, 2013; Sela et al.,
2012; Singh et al., 2013; Singh and Dalton, 2009). Weak
transcriptional activation of developmental regulators has
also been described in the G1 phase of self-renewing
PSCs, accounting for population heterogeneity, but impor-
tantly also indicates that developmental genes are suscepti-
ble to transient activation during a narrow window of time
during the cell cycle (Singh et al., 2013). These studies
therefore suggest that the G1 phase represents a ‘‘window
of opportunity’’ that places PSCs in a poised state. Despite
the link between cell-cycle position and responsiveness to
differentiation signals, the molecular mechanism under-
pinning this is not well understood.
In this report, we show that the bivalent state is not
stable in PSCs but highly dynamic and cell-cycle regu-
lated, thereby establishing ‘‘lineage-poised’’ and ‘‘lineage-
restricted’’ states in PSCs. The cell-cycle machinery directs
recruitment of the MLL2 (KMT2B) HMT complex to
developmental genes, allowing for bivalent domains to
be transiently established during a narrow window of
time during G1, thus explaining the true nature of the
poised state and a rationale for why cells commit to
differentiation from G1. A key aspect of developmental
gene activation is the reorganization of chromatin
following establishment of the bivalent domain and
recruitment of functionally important enhancers. TheseReports j Vol. 5 j 323–336 j September 8, 2015 j ª2015 The Authors 323
Figure 1. H3K4 Trimethylation Is Cell-Cycle Regulated at Bivalent Domains of Developmentally Regulated Genes
(A) Diagram of the Fucci reporter system established in WA09 hESCs.
(B) The Fucci system can be used to isolate cell-cycle fractions in live hESC cells by FACS.
(C) qRT-PCR of Fucci-sorted cells exhibit periodicity of transcription for developmental genes. Data are the average of technical triplicates
and representative of more than ten independent experiments.
(D) ChIP-seq of bivalent genes with cell-cycle-regulated H3K4me3 (>2-fold change between any two fractions) represented as a heatmap.
Representative, developmental genes belonging to different cell-cycle-regulated clusters are shown. ChIP-seq data are from the pool of
three independent experiments.
(legend continued on next page)
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findings presented here have broad implications for other
multipotent cell populations.RESULTS
The Bivalent State Is Unstable, Dynamic, and
Cell-Cycle Regulated
Combined with fluorescent-activated cell sorting (FACS),
the Fucci system (Sakaue-Sawano et al., 2008) allows cell-
cycle events to be monitored without physiological pertur-
bation induced by synchronizing drugs (Figures 1A and
1B). By RNA sequencing (RNA-seq) analysis of FACS-iso-
lated human embryonic stem cell (hESC) Fucci cell-cycle
fractions, we previously showed that transcription of devel-
opmental genes representative of the three embryonic
germ layers (ectoderm, definitive endoderm [DE], and
mesoderm) peaks during late G1 (Singh et al., 2013). This
peak of transcription continues during the early stages of
DNA replication but declines as cells transition through
S phase and remains low for the remainder of the cell cycle
(Figure 1C) (Singh et al., 2013). Since bivalent domains of
histone modifications are known to regulate develop-
mental genes in PSCs by placing them in a poised state
(Bernstein et al., 2006; Mikkelsen et al., 2007), we reasoned
that they could be subject to cell-cycle control, thus ex-
plaining why many of these genes display transcriptional
periodicity. To assess this possibility, we performed chro-
matin immunoprecipitation sequencing (ChIP-seq) anal-
ysis of H3K4me3 and H3K27me3 on Fucci hESC cell-cycle
fractions (Tables S1 and S2). Approximately half of all biva-
lent genes (Sharov and Ko, 2007) show cell-cycle-linked
periodicity for H3K4 trimethylation (1,029 of 2,095).
Approximately 90% of these genes show increased
H3K4me3 as cells transition through late G1 and perform
roles primarily associated with developmental processes
(Figure S1A). Consistent with RNA-seq data (Singh et al.,
2013), H3K4me3 levels for bivalent genes that associated
with specification of all three embryonic germ layers
peaked in late G1 and declined during S phase (Figures
1D–1F and S1B). The residual group of bivalent genes dis-
plays no transcriptional periodicity or cell-cycle-dependent
H3K4me3 and performs roles in non-developmental pro-(E) Bean-plot diagram showing distribution of H3K4me3 levels for cell-
median values. Late G1 was significantly higher than S (p < 13 1014)
pool of three independent experiments.
(F) H3K4me3 ChIP-seq profiles of hESC Fucci fractions for GATA6 and
given in RPM. ChIP-seq data are from the pool of three independent
(G) GO analysis comparing cell-cycle-regulated bivalent genes and no
(H) H3K4me3 qChIP using Fucci-isolated cell-cycle fractions from ES
three independent replicates.
*p < 0.05. Error bars in this figure represent the SEM. See also Figure
Stem Cellcesses such as metabolism (Figures 1G, S1B, and S2A).
Pluripotency regulators (OCT4, NANOG) and house-keep-
ing genes (ADCY4, ESPN, GRM2) are constitutively H3K4
trimethylated in regions proximal to their transcription
initiation sites (Figure S1B), and their transcripts show no
periodicity during the cell cycle (Figure S1C) (Singh et al.,
2013). ChIP-seq of H3K27me3 showed that this mark is
not cell-cycle regulated (Figures S2B and S2C; Table S2).
We validated the ChIP-seq data using quantitative ChIP-
PCR (qChIP) for GATA6 and SOX17 (Figures 1H and S2D).
Finally, we decided to examine how rapidly the loss of
developmental transcripts and H3K4me3 occurs upon exit
from G1 (Figures S2E and S2F). By evaluating early S-phase
cells (i.e., those cells double positive for Az1 and KO2), we
find that the loss ofH3K4me3precedes the loss of transcript
levels, indicating a role for transcript degradation as cells
exit the poised state. In summary, bivalent genes associated
withdevelopmental processes tend tobe transcribedduring
the late G1 phase in hPSCs—this is correlated with
increased H3K4 trimethylation in the domain proximal to
TSSs. Bivalent domains are therefore primarily established
in G1 and far more dynamic than previously believed.
This challenges the conventional view of what bivalent
modifications represent, how they are established and
maintained, and what the poised pluripotent state is.
MLL2 Activity Is Cell-Cycle Regulated and
Dynamically Regulates Bivalent Domains
MLL2-containing HMT complexes are primarily respon-
sible for H3K4me3 deposition at bivalent genes in ESCs
(Denissov et al., 2014; Hu et al., 2013). MLL2 assembles
into complexes with MENIN, which functions by recruit-
ment of MLL1/2-specific complexes to chromatin and
with other subunits such asWDR5 that are shared by other
SET-family HMT complexes (Schuettengruber et al., 2011).
To establish whether cell-cycle-dependent MLL2 activity
could account for transcriptional periodicity and deposi-
tion of H3K4me3 during G1, we tested whether its recruit-
ment to developmental genes was cell-cycle regulated. By
qChIP, we found that MLL2 was significantly enriched at
GATA6 and SOX17 promoters in late G1 (Figure 2A), coin-
ciding with increased H3K4me3 and transcript levels (Fig-
ures 1C–1F), but showed no periodicity in binding tocycle-regulated bivalent genes. The black horizontal line represents
. Statistical analyses are described in ChIP-seq data and are from the
SOX17. Scale bar indicates genomic distance in kb and value range
experiments.
n-cell-cycle-regulated bivalent genes.
Cs or DE at the GATA6 or SOX17 promoters. Data are the average of
s S1 and S2 and Tables S1 and S2.
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Figure 2. The MENIN/MLL2 H3K4 Methyl Transferase Is Cell-Cycle Regulated and Controls the Activation of Bivalent Genes in G1
(A) qChIP of Fucci hESC cell-cycle fractions examining levels of MLL2 and WDR5 on the GATA6 and SOX17 promoters. Data are the average of
three independent replicates.
(B) qChIP assays for MLL2 in untreated or MI-2 (25 mM for 24 hr)-treated WA09 ESCs at the indicated promoters. Data are the average of
three independent replicates.
(C) qChIP assays for MLL2 in ESCs of pluripotency genes. Data are the average of three independent replicates.
(legend continued on next page)
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non-cell-cycle-regulated bivalent genes (Figure S1D). Other
components of the MLL2-HMT complex such as WDR5
display no periodicity in binding activity (Figure 2A).
The small molecule MI-2 (Grembecka et al., 2012) blocks
the MENIN-MLL2 interaction and as anticipated reduced
recruitment of MLL2 to developmental genes such as
GATA6, SOX17, PAX6, and OLIG2 (Figure 2B). MLL2 did
not bind non-bivalent genes such as NANOG or OCT4 (Fig-
ure 2C). Next, we evaluated the role of MLL2/MENIN in
ESCs and during DE differentiation. Here, MI-2 blocked
the cell-cycle regulation of GATA6 and SOX17 (Figure 2D),
along with the upregulation of developmental genes
(GATA6, GATA4, FOXA2, SOX17), whereas non-endoderm
genes such as NANOG, SOX2, FOXD3, CD9, and REX1
were unchanged or slightly upregulated (Figure S3A). Inhi-
bition of the MENIN-MLL2 complex also blocked the
upregulation of BRACHYURY, SOX17, and FOXA2 protein
(Figure 2E). Recent studies indicate that loss of MLL2 may
be compensated for by MLL1 (Denissov et al., 2014),
so to circumvent this potential problem, we blocked
MLL1/2 function by reducing levels of their common
HMT-binding partner, MENIN. As anticipated, shRNA
knockdown ofMENIN leads to a loss of H3K4me3 on devel-
opmental genes (Figure S3B). Reduction of MENIN activity
prevented the normal upregulation of protein levels for
CXCR4, SOX17, and FOXA2, along with endoderm tran-
scripts (GATA6 and FOXA2) (Figures 2F–2I). Collectively,
these data indicate that MENIN-MLL2 HMT complexes
are required for lineage priming through regulation of biva-
lent domains in PSCs and then for activation of the same
developmental genes under differentiation conditions.
The Cell Cycle ControlsMLL2 Recruitment to Bivalent
Genes
The accumulation of H3K4 trimethylation at bivalent do-
mains and a parallel increase in transcription of these genes
suggest a role for cyclin-dependent protein kinase (CDK) ac-
tivities during the late G1 to early S-phase period. Themost
likely candidate was CDK2 because its activity is most
closely associated with transition through late G1 phase(D) qRT-PCR transcript analysis of Fucci-sorted hESCs after treatment
average of three independent replicates.
(E) Immunoblot analysis of WA09 hESC and DE (2 days) lysates (20 m
(F) Immunostaining for SOX17 (top) and FOXA2 (bottom) following th
or cells differentiated to DE for 3 days. Cells are co-stained with DAP
(G) Quantitation of immunostaining represented in (E) for three ind
pendent experiments.
(H) CXCR4 flow cytometry analysis of WA09 hESCs and DE (3 days dif
percentage of CXCR4+ cells in each condition is indicated.
(I) qRT-PCR transcript analysis of WA09 hESCs and DE (3 days differen
[C]) shRNA. Data are the average of three independent replicates.
*p < 0.05. Error bars in this figure represent the SEM. See also Figure
Stem Celland early S phase in cycling cells (Bertoli et al., 2013). To
determine whether CDK2 activity was required for MLL2
recruitment to bivalent genes, we added the inhibitor
CVT-313 (Brooks et al., 1997) for a brief period (4 hr) so as
not to impose a cell-cycle block, andnomajorperturbations
in cell-cycle progression were observed during this time
(Figure 3A). The addition of CVT-313 suppressed develop-
mental transcripts had no effect on OCT4 transcripts or
transcripts for non-cell-cycle-regulated bivalent genes, and
significantly reduced MLL2 recruitment to developmental
genes (Figures 3B, 3C, and S3C). MENIN binding, however,
was not affected by CDK2 inhibitor treatment (Figure 3C).
Previous studies seeking to identify CDK2 substrates
discovered that MLL2 is phosphorylated by CDK2 on thre-
onine-5099 (Badeaux and Shi, 2013; Chi et al., 2008).
Immunoprecipitation of MLL2, followed by immunoblot-
ting for phospho-serine and phospho-threonine residues,
in the presence or absence of the CDK2 inhibitor, CVT-
313, confirmed that MLL2 is a bona fide CDK2 target
(Figure 3D). SinceMLL2 binding is stable onnon-cell-cycle-
regulated bivalent genes (Figure S1D), we reasoned that
CDK2 may phosphorylate MLL2 to facilitate its binding
only for cell-cycle-regulated bivalent genes. In support of
this, we find that CDK2 specifically binds to developmental
gene promoters (Figure S3D). Finally, a constitutively active
version of CDK2 was expressed in hESCs and its effects
compared with that of an inactive mutant (Chytil et al.,
2004). Here, increased CDK2 activity promoted recruit-
ment of MLL2 to GATA6 and SOX17 promoters compared
with the control (Figure 3E). We conclude that CDK2 sig-
nals throughMLL2 to establish H3K4me3-marked bivalent
domains in G1 (Figure 3F). This explains the small pulse of
G1-specific transcription of developmental genes described
previously (Singh et al., 2013).
Bivalent Genes Undergo Chromatin Remodeling
during the Cell Cycle to Establish Promoter-Enhancer
Interactions
Since the epigenetic status of a gene is often closely corre-
lated with its chromatin structure, we asked whetherwith the MLL/MENIN inhibitor, MI-2 (25 mM for 24 hr). Data are the
g per lane) with or without MI-2 (25 mM).
e infection of GFP-control or MENIN shRNA lentivirus in WA09 hESCs
I to visualize nuclei. Micron bar represents 50 mm.
ependent fields, n > 1,000. Data are representative of three inde-
ferentiation) transduced with MENIN or GFP shRNA lentivirus. The
tiation) following lentiviral infections with MENIN or GFP (control
S3.
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Figure 3. CDK2 Phosphorylates MLL2 to Regulate Its Binding
(A) Cell-cycle Fucci profiles of untreated and CDK2 inhibitor (CDK2I, CVT-313, 20 mM) treated cells for 4 hr.
(B) qRT-PCR analysis of transcript levels in ESCs treated with CVT-313 for 4 hr. Data are the average of three independent replicates.
(C) qChIP for MLL2 and MENIN in ESCs treated with CVT-313 for 4 hr. Data are the average of three independent replicates.
(D) MLL2 immunoprecipitations (IPs) from ESC lysates (200 mg protein; ±CVT-313) were probed with MLL2, phospho-threonine (pTP), or
phospho-serine (pSP) antibodies. IgG was used as an IP control, and whole cell lysate was immunoblotted (input) alongside IPs.
(E) ESCs were transfected with a construct expressing constitutively active (CA) or inactive (KE mutant) CDK2-CCND1 gene fusion driven by
CAGi promoter, and then qChIP assays for MLL2 were performed 36 hr later for GATA6 and SOX17. Data are the average of three independent
replicates.
(F) Model depicting the cell-cycle control of bivalent domains. All data are representative of biological replicates.
Error bars in this figure represent the SEM. *p < 0.05.
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chromosome dynamics around developmental genes
change in the cell cycle and whether this is regulated by
changes in H3K4 trimethylation status at bivalent do-
mains. This was approached by circular chromatin confor-
mation capture sequencing (4C-seq) assays (Gheldof et al.,
2012; Splinter et al., 2012) in the four Fucci cell-cycle frac-
tions. Focus was directed toward GATA6 and SOX17
because these two genes have cell-cycle-regulated tran-
scription and H3K4me3 patterns. For this analysis, we
used TSSs for GATA6 and SOX17 as ‘‘viewpoints’’ and
analyzed regions spanning 1 Mb upstream and down-
stream. This generated ‘‘domainograms’’ to provide a visual
representation of regional chromosome architecture (Fig-
ures 4A and 4B). Although most chromatin structures
around these genes remain intact during the cell cycle,
several changes were identified by subtractive analysis of
4C data plots (Figures 4A, 4B, and S4A–S4D). Interestingly,
several chromatin structures were established as cells
transitioned from early G1 to late G1 and then lost as cells
transition through S phase. These cell-cycle-regulated
chromatin loop structures were validated by chromatin
conformation capture qPCR (3C-qPCR) in separate biolog-
ical samples (Figure S4E).
To characterize the functional significance of G1-specific
chromosome structures, we asked whether loop contact re-
gions overlap with known gene regulatory elements using
data provided by the NIH Roadmap Epigenomics Project
(http://www.roadmapepigenomics.org), along with chro-
matin state dynamics analysis in hESCs (Ernst et al.,
2011). Several interaction sites were identified thatmapped
to enhancer elements, based on histone modification pro-
files (Table S3). ChIP-seq for H3K27ac and H3K4me1
enhancer marks was then performed to independently
evaluate the epigenetic landscape aroundG1-specific struc-
tures in the four Fucci cell-cycle fractions (Figure 4C). Spe-
cific focuswas on loops that form inG1 phase at theGATA6
and SOX17 loci (Figures 4C and S5C–S5E). These data show
that cell-cycle-regulated architectural changes facilitate in-
teractions between bivalent promoters with active en-
hancers in late G1. Enhancer histone marks do not appear
to vary with cell-cycle position at enhancers or promoters
(Figures 4C and S4F), indicating that they are not respon-
sible for architectural changes around bivalent genes inG1.
Studies so far have focused on the bivalent, poised plurip-
otent state where developmental genes are transiently acti-
vated and domains of H3K4 trimethylation are temporarily
established in late G1. We then asked whether these loops
that showed enrichment of histone marks associated with
enhancers are relevant under conditions when develop-
mental genes are activated during lineage-specific differen-
tiation. To investigate whether cell-cycle-regulated loops at
GATA6 and SOX17 loci also form duringDE differentiation,
we performed 3C-qPCR analysis. This analysis showed thatStem Cellcell-cycle-regulated loops identified in PSCs were main-
tained at these genes as they become fully activated during
DE differentiation (Figure 4D). Continued MENIN/MLL2
activity and CDK2 activity are required for maintenance
of these loops as brief exposure to MI-2 and CDK inhibitor
erased these architectural structures.Cell-Cycle-Dependent Recruitment of Enhancers Is
Required for Activation of Bivalent Genes
4C-seq identified enhancers that interact in a cell-cycle-
regulated manner with GATA6 and SOX17 bivalent pro-
moters. To demonstrate that these enhancers are important
for gene activation and differentiation, we utilized CRISPR
technology to delete two of these elements. By using two
CRISPR guide RNAs, along with a targeting vector consist-
ing of 1 kb homology arms and a reporter cassette contain-
ing a CAGi promoter driving BFP-IRES-Zeocin, we deleted
the enhancer for GATA6 that corresponded to interaction
from loop #10 in Fucci hESCs (Figure S5). Deletion of this
enhancer blocked the upregulation ofGATA6 transcription
under differentiation conditions, while other genes such as
BRACHYURY and FOXA2 were activated as expected (Fig-
ure 5A). Using FACS-sorted hESC Fucci fractions, the spe-
cific loss of GATA6 transcripts in late G1 was confirmed
(Figure 5B).
Using a similar approach, an enhancer that forms part of
a cell-cycle-dependent loop at the SOX17 locuswas also dis-
rupted (Figure S6). Disrupting this enhancer blocked
SOX17 transcription during endoderm differentiation,
while other endoderm genes such as EOMES and GSC
were activated with typical kinetics and magnitude (Fig-
ure 5C). In addition, we confirmed that the loss of SOX17
transcripts was specific to the lateG1 phase by sorting Fucci
fractions in hESCs (Figure 5D). Finally, we showed that cells
lacking an intact, cell-cycle-regulated enhancer at the
SOX17 locus failed to accumulate SOX17 protein during
DE differentiation (Figures 5E and 5F). In contrast, EOMES
expression was unaffected. These data demonstrate that
cell-cycle-dependent chromosome architectural changes
are critical for activation of developmentally regulated
genes. Bivalent marks regulated by CDK-dependent signals
are an absolute requirement for architectural changes and
for normal transcriptional activation during differentia-
tion. An overall model depicting our results is shown in
Figure 6.DISCUSSION
In 2006, Bernstein and colleagues showed that develop-
mental genes are held in a poised chromatin state by do-
mains of overlapping H3K4me3 and H3K27me3 histone
marks proximal to TSSs. The basic assumption of thisReports j Vol. 5 j 323–336 j September 8, 2015 j ª2015 The Authors 329
Figure 4. Functional Chromosome Architectural Changes Occur around Bivalent Genes in G1
(A and B) Domainograms from 4C-seq analysis of GATA6 (A) and SOX17 (B) depicting subtractions between cell-cycle fractions as indicated,
with 1 Mb regions upstream and downstream of the viewpoints (V) (GATA6 chr18:19,753,020-19,754,093; SOX17, chr8:55372547-
55373246).
(C) Spider-plot diagrams are shown for two interaction loops (with approximate distances from the viewpoint) that map to putative
enhancers at GATA6 or SOX17 loci (top). ChIP-seq profiles for H3K4me1 and H3K27ac in Fucci cell-cycle fractions and from ENCODE data in
WA01 (H1) hESCs for putative enhancer loops identified (bottom). The ChromHMM track identifies chromatin features based on the
local epigenetic landscape (green, transcribed region; yellow, weak enhancer; orange, strong enhancer; and blue, insulator). Range is
given in RPM.
(legend continued on next page)
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model was that in an H3K4me3-marked state, repressive
domains serve to silence developmental genes. Following
exposure to specification signals, these genes then become
rapidly activated following erasure of the H3K27me3
domain. Recently, however, we showed that instead of be-
ing silent, bivalently marked genes are transcribed during
the late G1 phase in human PSCs (Singh et al., 2013). In
this report, we provide a mechanism for this by showing
that H3K4me3 domains are only established at develop-
mental genes in G1 phase and that this is due to cell-cycle-
dependent recruitment of the HMT complex subunit
MLL2. These observations establish that bivalent domains
are highly unstable and form only during a narrowwindow
of time during the cell cycle. Moreover, they show that
PSCs alternate between the poised and lineage-restricted
states.
The brief activation of developmental genes in late G1
phase explains why PSCs are prone to initiate differentia-
tion from this period of the cell cycle (Chetty et al., 2013;
Jonk et al., 1992; Mummery et al., 1987; Pauklin and Val-
lier, 2013; Sela et al., 2012; Singh et al., 2013), but the ques-
tion of why G1 is special in terms of cell-fate decisions is
not immediately obvious. The most likely explanation is
that a ‘‘permissive’’ chromatin environment is established
in G1 allowing for transcription factor loading and chro-
matin remodeling immediately after chromosome segrega-
tion but before replication (Egli et al., 2008). This is
supported by observations showing that de novo chro-
matin domains are preferentially established during G1
phase of the cell cycle (Thomson et al., 2004). Data in
this report provide the first detailed evidence at the molec-
ular level to support this model.
While the majority developmental transcription factors
display periodicity for H3K4me3 on their gene promoters,
some such as BRACHYURY, do not. Similarly, BRACHYURY
transcript does not oscillate during the cell cycle (Singh
et al., 2013). Further studies will be needed to understand
how this small subset of developmental genes and the
remaining non-cell-cycle-regulated genes involved in
metabolism are transcriptionally regulated and how this
impacts upon lineage specification. Consistent with the
stable H3K4me3 and transcript levels of non-cell-cycle-
regulated bivalent genes, we find that MLL2 binding does
not oscillate on their promoters during the cell cycle. Since
the non-cell-cycle-regulated bivalent genes represent
approximately 50% of all bivalent genes, this also explains
why the total levels of MLL2 phosphorylation did not peak
in late G1 (data not shown). Phosphoregulation of MLL2 is(D) 3C-qPCR examining cell-cycle-regulated interaction loops in WA09
(25 mM) for the final 24 hr or CVT-313 (20 mM) for the final 4 hr. Dat
pendent replicates.
*p < 0.05. Error bars in this figure represent the SEM. See also Figure
Stem Celllikely to be a complex process. We evaluated this issue in
cell-cycle fractions, and although phosphorylated in a
CDK2-dependent manner in G1, MLL2 is also phosphory-
lated in other cell-cycle phases when CDK2 is less active.
This indicates that other CDKs and non-CDKs control
MLL2 activity. It is possible, for example, that CDK2
controls MLL2 recruitment to bivalent genes in G1, while
other phosphorylation events regulate its recruitment to
other targets and possibly release from bivalent genes
outside of G1.
A second major aspect of the poised, bivalent state in-
volves changes in chromosome architecture around devel-
opmental genes in G1. Following recruitment of MLL2 and
deposition of H3K4me3, distal enhancers are recruited to
proximal sites by a looping mechanism. Recruitment of
enhancer-containing structures to developmental genes is
dependent on the establishment of bivalent domains in
G1 and not by epigenetic changes at the enhancer itself.
The cell-cycle-dependent structures and their associated
enhancers persist during DE differentiation are critical for
transcriptional activation and are important for the differ-
entiation program itself. Results described in this report
provide a foundational mechanism to explain the poised
state originally described by Bernstein and colleagues
several years ago. Our data show that rather than being in
a stable poised state, hPSCs are only bivalent and poised
for differentiation during G1 phase. This raises many ques-
tions about the regulation of H3K4 trimethylation that
have not been addressed by this study. For example, how
are H3K4me3 marks rapidly erased in S phase? Are histone
de-methylases under the control of the cell-cycle machin-
ery? Are bivalent domains in multipotent stem cells under
the control of the cell cycle? Future studies are needed to
address these important questions.
In summary, this report defines a level of regulation that
is of fundamental importance to pluripotency and to
mechanisms of cell-fate commitment. By establishing links
between the cell-cycle machinery, epigenetic regulators,
and chromatin architecture, we now have a framework
that can be used to further explore the fundamental aspects
of pluripotency and cell-fate specification.EXPERIMENTAL PROCEDURES
hESC Culture and Differentiation
Fucci WA09 hESCs were generated and grown as described
previously in media containing HEREGULIN b1 (10 ng/ml, Pepro-
tech), ACTIVIN A (10 ng/ml, R&D Systems), and LONGR3 IGF-1ESCs and DE (3-days differentiation) following treatment with MI-2
a are normalized to ESC levels. Data are the average of three inde-
S4 and Table S3.
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Figure 5. Cell-Cycle-Dependent Recruitment of Enhancer Elements Are Required for the Activation of Bivalent Genes
(A) Organization of the GATA6 locus around a region displaying cell-cycle-dependent changes in chromosome architecture. The specific
loop structure (loop #10), its associated enhancer region, and CRISPR-Cas9-directed disruption of a 1 kb region encompassing the
(legend continued on next page)
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Figure 6. Model Depicting How the Cell Cycle Regulates Bivalent Domains and Chromatin Structure during Self-Renewal and
Differentiation of PSCshuman (200 ng/ml, Sigma) (Singh et al., 2013; Singh et al.,
2012). Endoderm differentiation was performed by removing
HEREGULIN b1 and IGF-1, and increasing the concentration of
ACTIVIN A to 100 ng/ml. SB431542 (20 mM, Tocris Bioscience),
U0126 (20 mM, LC Laboratories), MI-2 (25 mM, Xcess Biosciences),
and CVT-313 (20 mM, EMD Biosciences) were used as indi-
cated. Expression constructs for CA-CDK2, a constitutively active
and stabilized CYCLIN D1- CDK2 fusion protein, and KE-CDK2,
a CYCLIN D1-CDK2 fusion protein carrying an inactivating
K114E mutation, were kind gifts from Brian Law (Chytil et al.,
2004).enhancer and the resulting insertion of a BFP reporter cassette are
genome-edited (deletion) ESCs was performed over the first 48 hr of
(B) Analysis of GATA6 transcript levels during the cell cycle in Fuc
(deletion; loop #10) cells. Data are the average of three independent
(C) Organization of the SOX17 locus around a region displaying cell-cyc
structure (loop #14), its associated enhancer region, and CRISPR-Cas9-
the resulting insertion of a BFP reporter cassette are indicated (top
(deletion) ESCs was performed over the first 48 hr of differentiation to
independent replicates.
(D) Analysis of SOX17 transcript levels during the cell cycle in Fuc
(deletion; loop #14) cells. Data are the average of three independent
(E) Immunostaining of WT (control) and genome-edited (SOX17 lo
(DE, 24 hr) conditions.
(F) Quantitation of immunostaining in (E) from three separate fields o
representative of three independent experiments.
*p < 0.05, **p < 0.01. Error bars in this figure represent the SEM. Se
Stem CellImmunostaining, Immunoblotting, and qRT-PCR
qRT-PCRwas performed using Taqman ‘‘Assays onDemand’’ (Invi-
trogen) on a Viia7 instrument (Life Technologies). All assays were
performed in triplicate, normalized toGAPDH, and analyzed using
the DDCT method. Data are representative of multiple indepen-
dent experiments. Immunoblotting, immunoprecipitations, and
immunostaining were performed as previously described (Singh
et al., 2012), with antibodies raised against MLL1 (A300-086A),
MLL2 (A300-113A, Bethyl Laboratories); MENIN (ab2605),
JMJD3 (ab85392, Abcam), WDR82 (kind gift from David Skalnik,
IUPUI School of Science); pSMAD2 (3104S), pSerine-CDKsindicated (top). qRT-PCR transcript analysis of WT (control) and
differentiation toward DE for indicated genes (bottom).
ci ESC cell-cycle fractions from WT (control) and genome-edited
replicates.
le-dependent changes in chromosome architecture. The specific lop
directed disruption of a 1 kb region encompassing the enhancer and
). qRT-PCR transcript analysis of WT (control) and genome-edited
ward DE for indicated genes (bottom). Data are the average of three
ci ESC cell-cycle fractions from WT (control) and genome-edited
replicates.
cus; loop #14) cells under self-renewal (ESCs) or differentiation
f view for each antibody (n > 1000). Micron bar is 100 mm. Data are
e also Figure S5.
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Substrate, P-S-100 (9477), pThreonine-Proline (9391) (Cell
Signaling Technology); OCT4 (sc-8628), CDK2 (sc-163) (Santa
Cruz Biotechnology); BRACHYURY (AF2085), SOX17 (AF1924)
(R&D systems); FOXA2 (07-633, Millipore).4C-Seq and 3C-qPCR
4C-seq analysis was performed as previously described (Splinter
et al., 2012). Approximately 10 million cells from FACS-isolated
Fucci hESC fractionswere fixed in 1% formaldehyde andquenched
with 1 M glycine. Following cell lysis, nuclei were digested with
Hind III and ligated overnight under diluted conditions. Following
the reversal of crosslinks, chromatin was digestedwithNla III over-
night. Next the chromatinwas re-ligated andused to generateDNA
libraries by PCR using the Expand Long Template Polymerase kit
(#11759060001, Roche). PCR primer details are available upon
request. PCR products were then purified using the High Pure
PCR Product Purification Kit (#11732676001, Roche) and used
for 3C-qPCR or 4C-seq. 3C-qPCR was performed using indicated
primers (Table S4) with Kapa SYBR Fast Kit (KK4602, KAPA
Biosystems) according to the manufacturer’s instructions on a
ViiA7 Real-Time PCR instrument (Life Technologies). 4C-seq was
performed using an Illumina HiSeq instrument to obtain 180–
200 M, 50 bp paired-end reads (HudsonAlpha). Following
sequencing, the resulting data were analyzed as follows. A refer-
ence genome was built for sites around Hind III sites. Reads were
then trimmed to remove adaptor sequences, followed bymapping
to the customized reference genome with Bowtie. p values were
then calculated for various window sizes and plotted as domaino-
graphs (de Wit et al., 2008). For differential interaction site identi-
fication between cell-cycle fractions, counts were normalized and
subtracted between samples, followed by p value calculations, as
performed for single-sample analysis. Log-transformed p values
were then summed at a window size of 16, and the resulting peaks
indicated the cell-cycle-regulated chromatin interactions. Human
genome hg19 is used for mapping.ChIP-Seq and qChIP
Human Fucci ESCs were sorted into early G1 (DN, double nega-
tive), late G1 (KO2, Kusabira orange-2), S phase (AzL, Azami green
low), and G2/M (AzH, Azami green high) fractions by FACS on a
MoFlo instrument (Beckman Coulter). WA09 hESCs expressing
no fluorescence, Cdt1-KO2 only, and Geminin-Az1 only, were
used as FACS gating controls. Following FACS isolation, cells
were fixed in 1% formaldehyde and quenched with 2.5 M glycine.
Approximately 10 million cells per sample were sonicated with a
Covaris S220 for 8 min at 200 cycles per burst. Chromatin
was collected and then enriched by ChIP with H3K4me3,
H3K27me3, H3K27ac, or H3K4me1 antibodies using Protein G
Dynabeads (Invitrogen). Sequencing samples were prepared
according to the manufacturer’s protocol and sequenced with an
Illumina HiSeq instrument (Hudson Alpha). In addition to the
ChIP-seq samples of histone marks, input samples were used as
sequencing controls. For each sample, 40 M reads were obtained
by single-end (50 bp) sequencing. Alignment of sequencing reads
against human genome (hg19) was performed using the Bur-
rows-Wheeler Aligner (BWA) tool (Li and Durbin, 2009) with
the default parameters documented in the bwa-0.5.9 version.334 Stem Cell Reports j Vol. 5 j 323–336 j September 8, 2015 j ª2015 The AUniquely mapped reads were chosen for the sequencing analysis.
To eliminate noise and to take into account the unequal total
numbers of reads for different sample, we identified the ChIP
signal enriched regions: the 2.5 kb region from 1 kb upstream of
the TSS to 1.5 kb downstream of the TSS as H3K4me3 signal-
enriched region. For each bivalent gene obtained from Sharov
and Ko (2007), we calculated the normalized RPM (reads per
million) at ChIP signal enriched regions for H3K4me3 and
H3K27me3, respectively. A list of bivalent genes was compiled
that show a >2-fold RPM change between any of the adjacent
cell-cycle time points and included these in heatmap analysis.
For ChIP-seq with immunoprecipitations against H3K27ac and
H3K4me1, reads were mapped using Bowtie (Langmead et al.,
2009). HPeak (Qin et al., 2010) was used to call peaks frommapped
reads. GeneOntology (GO) analysiswas conducted using R (http://
www.r-project.org/). Differential binding sites were identified
using a conditional binomialmodel based on counts falling in spe-
cific peak regions of each sample. Histone tracks in H1 hESCs
(H3K4me1 and H3K27ac) from ENCODE and chromatin state dy-
namics (ChromHMM) tracks (Ernst et al., 2011) were downloaded
for inclusion in ChIP-seq analysis. The categories considered as
strong or weak enhancers had overlapping H3K27ac peaks. qChIP
was performed as previously described using theKapa SYBR Fast Kit
(KK4602, KAPA Biosystems) according to the manufacturer’s in-
structions on a ViiA7 Real-Time PCR instrument (Life Technolo-
gies). Antibodies for ChIP were as follows: H3K4me3 (ab8580
and ab1012, Abcam), H3K27me3 (ab6002, Abcam), H3K4me1
(ab8895, Abcam), H3K27ac (ab4729, Abcam), MENIN (ab2605,
Abcam), Wdr5 (ab56919, Abcam), MLL2/TRX2 (A300-113A,
Bethyl Laboratories), and Cdk2 D12 antibody (sc-6248. Santa
Cruz Biotechnology). See Table S4 for primer sequences.Genome Editing with CRISPR-Cas9
For genome editing at theGATA6 and SOX17 loci, target sequences
for guide RNAs (gRNA) were designed using http://crispr.mit.edu/.
Two gRNAswere used for each locus. The following sequences were
used for gRNAs: GATA6, upper gRNA1: TGTACGAATTACAATT
TGGCTGG, GTTATGTACGAATTACAATTTGG, lower gRNA2:
AAATGTTAGGCTTAATCAAATGG, AATGGCATAGCCTCAATACT
TGG; SOX17, upper gRNA1: GCAATGAAAGTCGCTGTCAGCGG;
and lower gRNA2: TTCACCCATTGCAAGCTTCCCGG. The target
gRNA expression constructs were ordered as individual 455 bp
gBlocks (Genscript), which has U6 promotor, target sequences,
guide RNA scaffold, and terminal signal, cloned into pUC57vector.
The specificity of the gRNAs was confirmed by transfecting the
gRNA construct with an hCas9 expression plasmid (#41815,
Addgene) into WA09 hESCs by lipofectamine 2000 for use in a
SURVEYOR assay as previously described (Ran et al., 2013). For per-
formance of gene knockouts in Fucci hESCs, a targeting plasmid
consisting of a CAG promoter driving BFP-IRES-Zeo with 1 kb ho-
mology arms was used to delete a 1 kb region containing the indi-
cated enhancer elements. Fucci hESCs were transfected with the
hCas9 plasmid, gRNA1 and gRNA2 plasmids, and the targeting
plasmid using the Neon transfection system (Invitrogen) accord-
ing to manufacturer instructions. Following transfection, hESCs
were selected with Zeocin for 2 weeks and further purified by
FACS isolation of BFP to isolate cells containing genomic deletions.uthors
Targeted deletion of the enhancer elements was verified by PCR
and agarose gel electrophoresis using primers within BFP and
outside of the homology arm. See Table S4 for primer sequences.
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